T2	Form 90 95	crema
T3	CHEM 99 109	rapamicina
#1	AnnotatorNotes T3	C0072980; sirolimus; Antibiotic · Organic Chemical
T4	PROC 110 130	aplicada tópicamente
T5	Route 119 130	tópicamente
T6	LIVB 133 142	pacientes
#2	AnnotatorNotes T6	C0030705; Patients; Patient or Disabled Group
T7	PROC 143 157	diagnosticados
#3	AnnotatorNotes T7	C0011900; Diagnosis; Diagnostic Procedure
T8	DISO 162 187	manchas en vino de Oporto
#4	AnnotatorNotes T8	C0235752; Port-Wine Stain; Congenital Abnormality
T10	CHEM 251 261	rapamicina
#5	AnnotatorNotes T10	C0072980; sirolimus; Antibiotic · Organic Chemical
T11	PROC 263 417	Estudio preliminar de la eficacia (dosis-respuesta) de fase II, con enmascaramiento doble, comparativo con un placebo, aleatorizado y con grupos paralelos
T12	Form 489 494	crema
T13	CHEM 498 508	rapamicina
#6	AnnotatorNotes T13	C0072980; sirolimus; Antibiotic · Organic Chemical
T14	PROC 509 529	aplicada tópicamente
T15	Route 518 529	tópicamente
T16	LIVB 532 541	pacientes
#7	AnnotatorNotes T16	C0030705; Patients; Patient or Disabled Group
T17	PROC 542 556	diagnosticados
#8	AnnotatorNotes T17	C0011900; Diagnosis; Diagnostic Procedure
T18	DISO 561 586	manchas en vino de Oporto
#9	AnnotatorNotes T18	C0235752; Port-Wine Stain; Congenital Abnormality
T19	LIVB 608 617	Pacientes
#10	AnnotatorNotes T19	C0030705; Patients; Patient or Disabled Group
T20	PROC 618 632	diagnosticados
#11	AnnotatorNotes T20	C0011900; Diagnosis; Diagnostic Procedure
T21	DISO 637 662	manchas en vino de Oporto
#12	AnnotatorNotes T21	C0235752; Port-Wine Stain; Congenital Abnormality
T24	LIVB 742 766	Pacientes de ambos sexos
T25	Age 770 789	≥3 meses y ≤18 años
T26	PROC 826 850	consentimiento informado
#14	AnnotatorNotes T26	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T27	LIVB 856 865	Pacientes
#15	AnnotatorNotes T27	C0030705; Patients; Patient or Disabled Group
T28	DISO 880 905	manchas en vino de Oporto
#16	AnnotatorNotes T28	C0235752; Port-Wine Stain; Congenital Abnormality
T29	ANAT 912 916	cara
#17	AnnotatorNotes T29	C0015450; Face; Body Location or Region | C1281591; Entire face; Body Location or Region
T30	ANAT 921 927	cuello
#18	AnnotatorNotes T30	C0007874; Cervix Uteri; Body Part, Organ, or Organ Component | C0027530; Neck; Body Location or Region | C1281592; Entire neck; Body Part, Organ, or Organ Component
T31	ANAT 932 938	tronco
#19	AnnotatorNotes T31	C0460005; Trunk structure; Body Location or Region | C1280632; Entire trunk; Body Part, Organ, or Organ Component
T32	ANAT 945 951	brazos
#20	AnnotatorNotes T32	C0446516; Upper arm; Body Location or Region | C1140618; Upper Extremity; Body Part, Organ, or Organ Component | C1269612; Entire upper arm; Body Part, Organ, or Organ Component
T33	DISO 971 996	manchas en vino de Oporto
#21	AnnotatorNotes T33	C0235752; Port-Wine Stain; Congenital Abnormality
T34	LIVB 1063 1072	pacientes
#22	AnnotatorNotes T34	C0030705; Patients; Patient or Disabled Group
T35	LIVB 1080 1102	representantes legales
T36	PHYS 1119 1129	comprender
T37	PROC 1149 1164	estudio clínico
#23	AnnotatorNotes T37	C0008972; Clinical Research; Research Activity | C0008976; Clinical Trials; Research Activity
T38	PROC 1184 1220	consentimiento informado por escrito
T39	LIVB 1252 1261	pacientes
#24	AnnotatorNotes T39	C0030705; Patients; Patient or Disabled Group
T40	LIVB 1269 1291	representantes legales
T41	LIVB 1327 1335	paciente
#25	AnnotatorNotes T41	C0030705; Patients; Patient or Disabled Group
T42	PROC 1350 1363	instrucciones
#26	AnnotatorNotes T42	C0220931; Training; Educational Activity
T43	LIVB 1368 1380	investigador
#27	AnnotatorNotes T43	C0035173; Research Personnel; Professional or Occupational Group
T44	LIVB 1387 1411	investigador colaborador
T45	LIVB 1421 1430	pacientes
#28	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T47	Form 1498 1503	crema
T50	ANAT 1570 1574	piel
#31	AnnotatorNotes T50	C1123023; Skin; Body System | C1278993; Entire skin; Body System
T51	LIVB 1652 1661	Pacientes
#32	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	PROC 1690 1701	tratamiento
#33	AnnotatorNotes T52	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T53	DISO 1705 1708	LCP
#34	AnnotatorNotes T53	C0023484; Leukemia, Plasma Cell; Neoplastic Process
T54	PROC 1724 1735	tratamiento
#35	AnnotatorNotes T54	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T55	ANAT 1773 1777	piel
#36	AnnotatorNotes T55	C1123023; Skin; Body System | C1278993; Entire skin; Body System
T56	LIVB 1843 1852	Pacientes
#37	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T57	DISO 1857 1860	MVO
T58	ANAT 1868 1889	extremidades distales
T59	ANAT 1901 1913	partes acras
T60	LIVB 1918 1927	Pacientes
#38	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group
T63	Neg_cue 1954 1956	no
T65	PROC 1974 1990	plan terapéutico
T66	PROC 2006 2033	evaluaciones de seguimiento
T67	Negated 2006 2033	evaluaciones de seguimiento
T68	LIVB 2039 2048	Pacientes
#39	AnnotatorNotes T68	C0030705; Patients; Patient or Disabled Group
T69	DISO 2053 2070	lesiones cutáneas
#40	AnnotatorNotes T69	C0037284; Skin lesion; Disease or Syndrome | C3241942; Sore on skin; Finding
T70	DISO 2084 2093	erosiones
#41	AnnotatorNotes T70	C0015256; Excoriation; Injury or Poisoning | C0040436; Tooth Erosion; Disease or Syndrome | C0333307; Superficial ulcer; Acquired Abnormality | C3887524; Skin Erosion; Disease or Syndrome
T71	DISO 2096 2103	úlceras
#42	AnnotatorNotes T71	C0041582; Ulcer; Pathologic Function
T72	LIVB 2109 2118	Pacientes
#43	AnnotatorNotes T72	C0030705; Patients; Patient or Disabled Group
T73	DISO 2123 2140	hipersensibilidad
#44	AnnotatorNotes T73	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding | C0585186; Cutaneous hypersensitivity; Disease or Syndrome
T74	LIVB 2203 2212	Pacientes
#45	AnnotatorNotes T74	C0030705; Patients; Patient or Disabled Group
T75	PROC 2232 2253	tratamiento sistémico
T76	CHEM 2258 2268	rapamicina
#46	AnnotatorNotes T76	C0072980; sirolimus; Antibiotic · Organic Chemical
T77	CHEM 2269 2278	sirólimus
#47	AnnotatorNotes T77	C0072980; sirolimus; Antibiotic · Organic Chemical
T78	CHEM 2280 2290	everólimus
#48	AnnotatorNotes T78	C0541315; everolimus; Organic Chemical · Pharmacologic Substance
T79	CHEM 2293 2305	temsirólimus
#49	AnnotatorNotes T79	C1707080; temsirolimus; Organic Chemical · Pharmacologic Substance
T80	Duration 2326 2337	los 3 meses
T81	PROC 2352 2365	reclutamiento
#50	AnnotatorNotes T81	C0242800; Patient Recruitment; Research Activity
T82	LIVB 2371 2380	Pacientes
#51	AnnotatorNotes T82	C0030705; Patients; Patient or Disabled Group
T83	PROC 2400 2421	tratamiento con láser
T84	PROC 2448 2471	intervención quirúrgica
#52	AnnotatorNotes T84	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T85	PROC 2477 2483	tratar
T86	DISO 2487 2511	mancha en vino de Oporto
#53	AnnotatorNotes T86	C0235752; Port-Wine Stain; Congenital Abnormality
T87	Duration 2532 2543	los 3 meses
T88	PROC 2558 2571	reclutamiento
#54	AnnotatorNotes T88	C0242800; Patient Recruitment; Research Activity
T89	LIVB 2591 2600	Pacientes
#55	AnnotatorNotes T89	C0030705; Patients; Patient or Disabled Group
T90	PROC 2631 2646	estudio clínico
#56	AnnotatorNotes T90	C0008972; Clinical Research; Research Activity | C0008976; Clinical Trials; Research Activity
T91	Duration 2667 2678	los 3 meses
T92	PROC 2700 2713	reclutamiento
#57	AnnotatorNotes T92	C0242800; Patient Recruitment; Research Activity
T93	LIVB 2719 2728	Pacientes
#58	AnnotatorNotes T93	C0030705; Patients; Patient or Disabled Group
T94	LIVB 2736 2748	investigador
#59	AnnotatorNotes T94	C0035173; Research Personnel; Professional or Occupational Group
T95	LIVB 2754 2778	investigador colaborador
T98	PROC 2833 2848	estudio clínico
#60	AnnotatorNotes T98	C0008972; Clinical Research; Research Activity | C0008976; Clinical Trials; Research Activity
T100	LIVB 2907 2914	Mujeres
#61	AnnotatorNotes T100	C0043210; Woman; Population Group | C0242665; wife; Family Group
T101	Neg_cue 2980 2982	no
T102	PROC 2992 3015	métodos anticonceptivos
#62	AnnotatorNotes T102	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T103	Negated 2992 3015	métodos anticonceptivos
T104	LIVB 3029 3036	varones
T105	Neg_cue 3061 3063	no
T106	PROC 3073 3096	métodos anticonceptivos
#63	AnnotatorNotes T106	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T107	Negated 3073 3096	métodos anticonceptivos
T108	LIVB 3113 3122	Pacientes
#64	AnnotatorNotes T108	C0030705; Patients; Patient or Disabled Group
T109	DISO 3127 3161	disfunción del sistema inmunitario
T110	PROC 3194 3220	tratamiento inmunodepresor
T1	PROC 44 83	Estudio de eficacia y búsqueda de dosis
T9	PROC 208 247	Estudio de eficacia y búsqueda de dosis
T22	DISO 687 712	Manchas en vino de Oporto
T23	PROC 1485 1503	aplicarse la crema
T46	DISO 1529 1553	mancha en vino de Oporto
T48	PROC 1628 1646	escala Fitzpatrick
T49	PROC 1819 1837	escala Fitzpatrick
T61	Negated 1974 1990	plan terapéutico
T111	PROC 1300 1322	cumplimentar el diario
T99	LIVB 2855 2874	Mujeres embarazadas
T112	PHYS 2891 2900	lactancia
T62	CHEM 2161 2185	componentes del producto
T64	Spec_cue 2919 2925	puedan
T113	PHYS 2935 2946	embarazadas
T114	Speculated 2935 2946	embarazadas
T96	Route 2244 2253	sistémico
